Trending Now
The market crashed almost 10 points
Small caps (IWM) retreated 0.54%, with the QQQ down 0.23%, which was more than the SPY at 0.14%. That’s the first time...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Translate Bio Inc (NASDAQ:TBIO) To Present On Its mRNA Platform’s Potential...
Translate Bio Inc (NASDAQ:TBIO) has announced that it will be one of the companies presenting at the 34th Annual North American Cystic Fibrosis Conference...
MAKE IT MODERN
LATEST REVIEWS
Compugen Ltd.’s (NASDAQ: CGEN) Computational Platform Uses Single-Cell Spatial Transcriptomics
Compugen Ltd. (NASDAQ: CGEN) has announced that it will present an exploration of the immune-time microenvironment using high resolution single-cell spatial transcriptomics at the...
MAKE IT MODERN
PERFORMANCE TRAINING
Futures turn green after the Iran saga
The Geopolitical uncertainty has simmered down, for the moment and The SPY moved up yesterday but has since fallen in premarket having...
GeoVax Labs Inc. (NASDAQ: GOVX) Publishes Its Efficacy Study of Modified Vaccine Ankara in...
GeoVax Labs Inc. (NASDAQ: GOVX) has announced the peer-reviewed animal efficacy trial's publication in the Nature Partner Journal (NPJ) Vaccines. The study focuses on...
Ibio Inc (NYSE:IBIO) Posts Revenues Of $0.8 Million In Q3 2021 From Manufacturing And...
Ibio Inc (NYSE:IBIO) reported revenues of $0.8 million from manufacturing and development services in Q3 2021. Its R&D expenses increased to $2.2 million in...
Heat Biologics Inc. (NASDAQ:HTBX) Receives Investigational New Drug Application Approval From The FDA For...
Heat Biologics Inc. (NASDAQ:HTBX) has announced that it has received FDA clearance for the Investigational New Drug application for PTX-35, which is developed by...
CASI Pharmaceuticals(NASDAQ: CASI) Partner BioInvent International AB receives ODD for BI-1206 in FL
CASI Pharmaceuticals (NASDAQ: CASI) has announced that the FDA has awarded its partner, BioInvent International AB, an Orphan Drug Designation for its experimental anti-FcyRIIB...
MAKE IT MODERN
